Hainan Huluwa Pharmaceutical Group (605199.SH) has been granted approval to conduct clinical trials for pediatric pulmonary heat cough and asthma granules.
ST Huluo Wa (605199.SH) announced that the company has recently received approval from the National Medical Products Administration regarding...
Hainan Huluwa Pharmaceutical Group (605199.SH) announced that the company has recently received the Drug Clinical Trial Approval Notification issued by the National Medical Products Administration regarding the Children's Pulmonary Heat Cough and Asthma Granules. This allows the product to carry out clinical trials for the treatment of pediatric influenza.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
